Economy

Navitas (NVTS) Soars to Fresh High on Nvidia Partnership, Support for Next-Gen AI

We have recently released an article titled Monstrous Gains: 10 Stocks Leaving Wall Street in the Dust. Notably, Navitas Semiconductor Corp. (NASDAQ:NVTS) stood out as a top performer on Tuesday.

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Economy

Why Dividend Stocks Are Better Bought Individually

Understanding Dividend Investing: SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Dividend investing has never been more popular. Investors often

Why Procurement Is the Utility Industry’s Critical Capacity Builder

The utility industry is facing a significant challenge as electricity demand is projected to increase by 25% by 2030 and

Exclusive-QIA, Visa and ADIA set to anchor SoftBank’s PayPay IPO, sources say

SoftBank's PayPay, a Japanese digital payments provider, is gearing up for a blockbuster U.S. initial public offering with a group

Steel Manufacturer Expects $875M Factory to Cut Foreign Dependency

U.S. Forged Rings (USFR) has recently announced its plans to establish a new factory in North Carolina, marking a significant

Michael Burry Warns Nvidia Looks Strikingly Similar to Cisco Just Prior to Dot Com Bubble Crash

Michael Burry Raises Concerns About Nvidia’s Supply Chain Michael Burry, the famed investor known for predicting the subprime mortgage collapse,

The US attacked Iran. Here’s what that means for you at the gas pump.

Oil prices surged on concerns of a potential war in the Persian Gulf, with the looming threat of U.S. and

River Road Loads Up on ATR With 917,000 Shares in New Position

River Road Asset Management, LLC recently made a significant move by establishing a new position in AptarGroup (NYSE:ATR) according to

Erasca, Inc. (ERAS): A Bull Case Theory

Erasca, Inc. (ERAS) is a biotech company that is currently focused on developing treatments for RAS/MAPK-driven cancers, which are a